IP Library Patent Application 11585577
Patent Application
App. No. 11/585,577

Methods and systems for determining mid-value titers

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/585,577
Abstract

The invention provides methods for determining the mid-value titer of a substance in a composition. In some methods the substance comprises at least one anti-hemagglutinin (HA) antibody. The invention also provides systems and computer-readable media for use in association with such methods.

Claims (53)

1 . A method for determining the mid-value titer of a substance in a composition, comprising:

selecting a series of dilution factors;

determining the standard titer of the substance in the composition; and

calculating the geometric mean titer between the standard titer and the lowest dilution factor in the series of dilution factors that is greater than the standard titer, to yield the mid-value titer of the substance in the composition.

2 . The method of claim 1 , wherein the substance is an antibody.

3 . The method of claim 1 , wherein the substance comprises at least one anti-hemagglutinin (HA) antibody.

4 . The method of claim 1 , wherein the composition comprises blood or blood serum.

5 . A method for determining the mid-value titer of a substance in a composition, comprising:

selecting a series of dilution factors;

determining the standard titer of the substance in the composition; and

calculating, using a computer and the following equation, the mid-value titer of the substance in the composition:

log T m =(log T s +log F )/2

in which T m is the mid-value titer, Ts is the standard titer, and F is the lowest dilution factor in the series of dilution factors that is greater than the standard titer.

6 . The method of claim 5 , wherein the substance is an antibody.

7 . The method of claim 5 , wherein the substance comprises at least one anti-hemagglutinin (HA) antibody.

8 . The method of claim 5 , wherein the composition comprises blood or blood serum.

9 . A method for determining the mid-value titer of a substance in a composition, comprising:

selecting a series of dilution factors;

determining the standard titer of the substance in the composition; and

calculating, using the following equation, the mid-value titer of the substance in the composition:

log T m =(log T s +log F )/2

in which T m is the mid-value titer, Ts is the standard titer, and F is the lowest dilution factor in the series of dilution factors that is greater than the standard titer.

10 . The method of claim 9 , wherein the substance is an antibody.

11 . The method of claim 9 , wherein the substance comprises at least one anti-hemagglutinin (HA) antibody.

12 . The method of claim 9 , wherein the composition comprises blood or blood serum.

13 . A system for determining the mid-value titer of a substance in a composition, the system comprising

a memory storage for maintaining a database and a processing unit coupled to the memory storage, wherein the processing unit is operative to:

select a series of dilution factors;

determine the standard titer of the substance in the composition; and

calculate the geometric mean titer between the standard titer and the lowest dilution factor in the series of dilution factors that is greater than the standard titer, to yield the mid-value titer of the substance in the composition.

14 . The system of claim 13 , wherein the substance is an antibody.

15 . The system of claim 13 , wherein the substance comprises at least one anti-hemagglutinin (HA) antibody.

16 . The system of claim 13 , wherein the composition comprises blood or blood serum.

17 . A system for determining the mid-value titer of a substance in a composition, the system comprising

a memory storage for maintaining a database and a processing unit coupled to the memory storage, wherein the processing unit is operative to:

select a series of dilution factors;

determine the standard titer of the substance in the composition; and

calculate, using the following equation, the mid-value titer of the substance in the composition:

log T m =(log T s +log F )/2

in which T m is the mid-value titer, Ts is the standard titer, and F is the lowest dilution factor in the series of dilution factors that is greater than the standard titer, to yield the mid-value titer of the substance in the composition.

18 . The system of claim 17 , wherein the substance is an antibody.

19 . The system of claim 17 , wherein the substance comprises at least one anti-hemagglutinin (HA) antibody.

20 . The system of claim 17 , wherein the composition comprises blood or blood serum.

21 . A computer-readable medium which stores a set of instructions which when executed performs a method for determining the mid-value titer of a substance in a composition, the method executed by the set of instructions comprising:

selecting a series of dilution factors;

determining the standard titer of the substance in the composition; and

calculating the geometric mean titer between the standard titer and the lowest dilution factor in the series of dilution factors that is greater than the standard titer, to yield the mid-value titer of the substance in the composition.

22 . A computer-readable medium which stores a set of instructions which when executed performs a method for determining the mid-value titer of a substance in a composition, the method executed by the set of instructions comprising:

selecting a series of dilution factors;

determining the standard titer of the substance in the composition; and

calculating, using a computer and the following equation, the mid-value titer of the substance in the composition:

log T m =(log T s +log F )/2

in which T m is the mid-value titer, Ts is the standard titer, and F is the lowest dilution factor in the series of dilution factors that is greater than the standard titer, to yield the mid-value titer of the substance in the composition.

Assignments (3)
CHANGE OF NAME Recorded Sep 6, 2012
From: SOLVAY BIOLOGICALS B.V.
To: ABBOTT BIOLOGICALS B.V.
Reel/Frame 028916/0127 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2008
From: SOLVAY PHARMACEUTICALS B.V.
To: SOLVAY BIOLOGICALS B.V.
Reel/Frame 021499/0539 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2007
From: NAUTA, JOZEF J.P.
To: SOLVAY PHARMACEUTICALS B.V.
Reel/Frame 018775/0297 →